Literature DB >> 15136809

Preparation of synthetic glycoconjugates as potential vaccines against Shigella flexneri serotype 2a disease.

Karen Wright1, Catherine Guerreiro, Isabelle Laurent, Françoise Baleux, Laurence A Mulard.   

Abstract

The synthesis of three neoglycopeptides incorporating carbohydrate haptens, differing in length, covalently linked to a non natural universal T helper peptide is disclosed. They were synthesized according to a blockwise strategy based on the condensation of appropriate di-, tri-, and tetrasaccharide trichloroacetimidate donors onto an azidoethyl 2-acetamido-2-deoxybeta-D-glucopyranoside acceptor. Use of thiol-maleimide coupling chemistry allowed site-selective efficient conjugation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15136809     DOI: 10.1039/b400986J

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  5 in total

1.  O-Acetylation in the O-specific polysaccharide isolated from Shigella flexneri serotype 2a.

Authors:  Joanna Kubler-Kielb; Evgeny Vinogradov; Chiayung Chu; Rachel Schneerson
Journal:  Carbohydr Res       Date:  2006-11-07       Impact factor: 2.104

2.  Structures of synthetic O-antigen fragments from serotype 2a Shigella flexneri in complex with a protective monoclonal antibody.

Authors:  B Vulliez-Le Normand; F A Saul; A Phalipon; F Bélot; C Guerreiro; L A Mulard; G A Bentley
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-10       Impact factor: 11.205

3.  Immunological evidence for functional rather than structural mimicry by a Shigella flexneri Y polysaccharide-mimetic peptide.

Authors:  Silvia Borrelli; Rehana B Hossany; B Mario Pinto
Journal:  Clin Vaccine Immunol       Date:  2008-05-07

4.  Investigation towards bivalent chemically defined glycoconjugate immunogens prepared from acid-detoxified lipopolysaccharide of Vibrio cholerae O1, serotype Inaba.

Authors:  Cyrille Grandjean; Alain Boutonnier; Bruno Dassy; Jean-Michel Fournier; Laurence A Mulard
Journal:  Glycoconj J       Date:  2008-07-23       Impact factor: 2.916

Review 5.  Carbohydrate moieties as vaccine candidates.

Authors:  Alexander H Lucas; Michael A Apicella; Christopher E Taylor
Journal:  Clin Infect Dis       Date:  2005-07-25       Impact factor: 9.079

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.